Montreal, Canada

Francois Quirion

This inventor holds 4 USPTO granted patents, plus 4 CIPO patents. Top assignees: Biomod Concepts Inc., Biomod Collection Inc., Nntt Tech Inc.. Active years: 2017-2020.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Francois Quirion

Introduction

Francois Quirion is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of manufacturing through his innovative patents. With a total of four patents to his name, Quirion has focused on creating articles of manufacture that effectively release active ingredients.

Latest Patents

Quirion's latest patents include advancements in articles of manufacture that release an active ingredient. These inventions relate to formulations that contain an active agent, which exhibits desirable properties when released from the articles. Additionally, his patents cover methods for manufacturing these articles, vehicles for applying the formulations, and perception indicators that signal the presence and quantity of the active agent applied.

Career Highlights

Throughout his career, Quirion has worked with various companies, including Biomod Concepts Inc. and NNTT Tech Inc. His work has been instrumental in developing innovative solutions that enhance product effectiveness and user experience.

Collaborations

Quirion has collaborated with talented individuals such as Karine Theberge and Isabelle Goudreault. These partnerships have contributed to the success of his projects and the advancement of his inventions.

Conclusion

Francois Quirion's contributions to the field of manufacturing through his innovative patents demonstrate his commitment to enhancing product functionality. His work continues to influence the industry and inspire future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…